European public procurement and grants data from official registers · Data as of 19 November 2026; updated daily.

Market report

Dermatological drug tenders in Czechia — market report, March 2025

Dermatological drug tenders in Czechia in March 2025: 8,827 tenders published (-5% month on month, +39% year on year), estimated at €167,261 in total, and 8,846 contracts awarded (-5% month on month, +40% year on year), worth €26,562,599 (awarded value). Buyers with the most tenders: Fakultní nemocnice Bulovka (2,729), Krajská nemocnice T. Bati, a. s. (2,453) and Krajská zdravotní, a.s. (814); most contracts won: ViaPharma s.r.o. (427), ROCHE s.r.o. (244) and Gilead Sciences s.r.o. (139). On average 1.4 bids per contract; 75% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
8,827
Contracts awarded
8,846
Contract value awarded
€26,562,599
Bids per contract
1.4
Tenders published per month
05K10KMar 24: 6,332Mar 24: 6,332Mar 24Apr 24: 6,740Apr 24: 6,740Apr 24May 24: 6,773May 24: 6,773May 24Jun 24: 6,695Jun 24: 6,695Jun 24Jul 24: 5,647Jul 24: 5,647Jul 24Aug 24: 5,777Aug 24: 5,777Aug 24Sep 24: 5,695Sep 24: 5,695Sep 24Oct 24: 7,005Oct 24: 7,005Oct 24Nov 24: 6,299Nov 24: 6,299Nov 24Dec 24: 6,565Dec 24: 6,565Dec 24Jan 25: 4,714Jan 25: 4,714Jan 25Feb 25: 9,302Feb 25: 9,302Feb 25Mar 25: 8,827Mar 25: 8,8278,827Mar 25
Contracts awarded per month
05K10KMar 24: 6,341Mar 24: 6,341Mar 24Apr 24: 6,746Apr 24: 6,746Apr 24May 24: 6,771May 24: 6,771May 24Jun 24: 6,702Jun 24: 6,702Jun 24Jul 24: 5,647Jul 24: 5,647Jul 24Aug 24: 5,776Aug 24: 5,776Aug 24Sep 24: 5,682Sep 24: 5,682Sep 24Oct 24: 7,008Oct 24: 7,008Oct 24Nov 24: 6,301Nov 24: 6,301Nov 24Dec 24: 6,569Dec 24: 6,569Dec 24Jan 25: 4,725Jan 25: 4,725Jan 25Feb 25: 9,292Feb 25: 9,292Feb 25Mar 25: 8,846Mar 25: 8,8468,846Mar 25

The highlighted bar is March 2025. Hover a bar for its figure; the table below has every value.

FigureMarch 2025February 2025ChangeMarch 2024Change
Tenders published8,8279,302-5%6,332+39%
Estimated value€167,261€122,469+37%€2,183,076-92%
Buyers3430+13%30+13%
Contracts awarded8,8469,292-5%6,341+40%
Contract value (awarded)€26,562,599——€4,404,025+503%
Winners279267+4%274+2%
Bids per contract1.41.8—1.3—
Single-bid contracts75%40%—89%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 6
  • Olomoucký kraj 3
  • Ústecký kraj 1

Procedures

  • not stated 8,817
  • Open procedure 10

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Dermatological and musculoskeletal drugs

Questions and answers

How many dermatological drug tenders were published in Czechia in March 2025?
8,827 (by 34 buyers); for comparison, February 2025: 9,302, March 2024: 6,332.
Who won the most dermatological drug tenders in Czechia in March 2025?
By number of contracts: ViaPharma s.r.o. (427), ROCHE s.r.o. (244), Gilead Sciences s.r.o. (139), Janssen-Cilag s.r.o. (135) and Takeda Pharmaceuticals Czech Republic s.r.o. (122); 279 companies won contracts in all.
Which buyers published the most dermatological drug tenders in March 2025?
Fakultní nemocnice Bulovka (2,729), Krajská nemocnice T. Bati, a. s. (2,453), Krajská zdravotní, a.s. (814), Fakultní nemocnice Brno (346) and Nemocnice České Budějovice, a.s. (306).
How competitive were dermatological drug tenders in Czechia in March 2025?
On average 1.4 bids per contract (20 contracts with a known number of bids); 75% of contracts had a single bid.
What were the contracts worth in March 2025?
€26,562,599 (awarded value, 8,846 contracts); median about €160,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.